[Corrigendum] Anti‐osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation
Long Wang,Wei-Guang Lu,Jun Shi,Hong-Yang Zhang,Xiao-Long Xu,Bo Gao,Qiang Huang,Xiao-Jie Li,Ya-Qian Hu,Qiang Jie,Zhuo-Jing Luo,Liu Yang
DOI: https://doi.org/10.3892/mmr.2023.13061
IF: 3.423
2023-08-02
Molecular Medicine Reports
Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, in Fig. 2A on p. 8311, portraying the results of immunostaining experiments for osterix, the 'GIOP' and 'GIOP+TMP (20)' data panels contained overlapping data, such that these images were derived from apparently the same original source, where they were intended to show the results from differently performed experiments. Moreover, in Fig. 3A on p. 8312 showing the results from ALP staining and Alizarin Red S staining experiments, two pairs of apparently overlapping data panels were identified in the Dex 106 M / TMP 50 μM, 100 μM and 200 μM data panels. After having re‐examined their original data, the authors have realized that the data featured in Figs. 2A and 3A were assembled incorrectly in these figures. Revised versions of Fig. 2 and 3, now containing replacement data for the experiments shown in Figs. 2A and 3A, are shown on the next page. Note that these errors did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 16: 8307‐8314, 2017; DOI: 10.3892/mmr.2017.7610]
oncology,medicine, research & experimental